BU.TO (BU) Fair Value & Analysis
Consumer Defensive · CA · Market cap C$23.6M
Risks
Fair value as of: Jul 15, 2026
From 1 valuation models · updated 37 days ago
Share price +7.2% over the past month.
Below-average quality, and screening another 84% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (C$0.4675). The favourable scenario is already priced in.
- Weak quality (23/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range (C$0.2295 to C$0.4675) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 15, 2026.
How to read this chart
60‑month range C$1.54 – C$77.58 · fair‑value band C$0.2295 – C$0.4675 · the C$1.94 price screens above the C$0.3145 fair value. Dashed = 300-day average. As of Jul 15, 2026.
Analysis
BU.TO (BU) currently trades at C$1.94, while our model-based Fair Value estimate is C$0.3145, implying the stock looks roughly 83.8% overvalued today. The Quality Score stands at 23/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at C$1.5M. Net debt stands at C$23.5M. Fundamentals as of Jul 15, 2026
Our scenario range runs from C$0.2295 (bear case) to C$0.4675 (bull case); at C$1.94, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 61% below its 52-week high and 28% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -14% fair-value upside, at -84%, BU screens richer than that median.
Notify me when BU reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 15, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 20 · Market factors (momentum, volatility) 15
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Burcon NutraScience Corporation, together with its subsidiaries, provides plant-based proteins for the food and beverage industry in Canada.
Full company description
Burcon NutraScience Corporation, together with its subsidiaries, provides plant-based proteins for the food and beverage industry in Canada. The company offers peas, which includes Peazazz, a pea protein for use in dairy alternatives; and canola protein, which comprises meat alternatives, egg alternatives, non-dairy frozen desserts, ready-to-mix beverages, whipped toppings and nutrition bars, and other concentrated protein supplements. It also provides soy that includes soy protein, a protein replacement for dairy proteins in food or in products, such as protein shakes, power bars, soups and sauces, meat alternatives, and breads and baked goods; and CLARISOY for sports nutrition beverages, citrus-based drinks, fruit-flavoured beverages, lemonades, powdered beverage mixes, and in various non-beverage plant-based applications. In addition, the company offers Solatein, a sunflower protein isolate; FavaPro fava protein and other plant proteins; hemp protein isolate; flax protein; and protein blends. The company was formerly known as Burcon Capital Corp. and changed its name to Burcon NutraScience Corporation in October 1999. Burcon NutraScience Corporation was incorporated in 1998 and is headquartered in Vancouver, Canada.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
BU.TO reported revenue of C$2.3M in FY2026 versus C$171K in FY2022, a compound +90.6%/yr. Reported net income was −C$14.3M in FY2026.
BU screens 84% overvalued. Compare with Nestlé India Limited →
Peer Group
Packaged Foods · 658 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé India Limited NESTLEIND | ₹1,507 | ₹362.37 | -76% |
| Britannia Industries Limited BRITANNIA | ₹5,511 | ₹1,765 | -68% |
| Tata Consumer Products Limited TATACONSUM | ₹1,062 | ₹327.27 | -69% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 7,550 IDR | 12,864 IDR | +70% |
| Samyang Foods Co 003230 | 1,219,000 KRW | 1,010,543 KRW | -17% |
| Vietnam Dairy Products Joint Stock Company VNM | 61,600 VND | 52,858 VND | -14% |
| Patanjali Foods Limited PATANJALI | ₹350.95 | ₹144.77 | -59% |
| PT Mayora Indah Tbk, MYOR | 1,650 IDR | 2,699 IDR | +64% |
| PT Cisarua Mountain Dairy Tbk CMRY | 4,610 IDR | 4,350 IDR | -6% |
| Nongshim Co 004370 | 389,500 KRW | 530,619 KRW | +36% |
Compare BU.TO with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is BU.TO (BU) overvalued or undervalued?
What is the fair value of BU?
What is the quality score of BU?
What is the revenue of BU.TO (BU)?
What is the net profit margin of BU?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track BU.TO and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.